Made with ❤️ by True Sparrow

Bringing you the latest funding data

Asher Biotherapeutics

Last funding round

Raised
$55,000,000
Round
Series C

Funding News (1)

Apr 16 2024Businesswire

Startup details

Asher Biotherapeutics

Asher Biotherapeutics

Asher Biotherapeutics is a biotechnology company focused on developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases. The company's lead program, AB248, is a highly differentiated CD8-targeted IL-2 immunotherapy currently in Phase 1b clinical trials.
asherbio.com
South San Francisco, California, United States
Established in 2019
11-50 People
Healthcare, Therapeutics

Founders

Ivana Djuretic

Ivana Djuretic

Founder and CSO

San Francisco, California, United States

Andy Yeung

Andy Yeung

San Francisco, California, United States

Investment details

Raised
$55,000,000
Round
Series C
Investors
RA Capital
LEAD
Bristol Myers Squibb
Boxer Capital
Third Rock Ventures
Wellington Management
Janus Henderson Investors
AstraZeneca

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United States

Jul2024
1

1 week ago

Cartken raised $22.5M led by 468 Capital
Miami and Tokyo-based Cartken specializes in sidewalk delivery robots for outdoor and indoor environments.
Cartken

Founders

Christian Bersch,

Anjali Jindal Naik

In News

TechCrunch
2

1 week ago

FreeBnk raised $3M from Founderheads and 2 others
FreeBnk is a fintech app offering affordable services for crypto investors, headquartered in New York
FreeBnk

Founders

Yunus Emre Ozkaya

In News

Finextra
3

1 week ago

VIDA raised a $3M Seed from Lightning Ventures and 3 others
Telecom-focused AI voice agents provider Vida
VIDA

Founders

Lyle Pratt

In News

MarTech Cube
4

2 weeks ago

Hummingbird Healthcare raised a $10M Series A led by UCHealth
Colorado-based Hummingbird Healthcare streamlines patient access and operational efficiency for healthcare providers.
Hummingbird Healthcare

Founders

Jeremy Schwach

In News

Hitconsultant
5

2 weeks ago

Pi Squared raised a $12.5M Seed led by Polychain Capital
Illinois-based Pi Squared enables verifiable computing through zero-knowledge technology for blockchain transactions and trustless remote computing.
Pi Squared

Founders

Patrick MacKay

In News

Coindesk
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.